Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059752
Filing Date
2024-05-14
Accepted
2024-05-14 17:00:36
Documents
39
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-20240331.htm   iXBRL 10-Q 1228633
2 EX-10.1 tcon-ex10_1.htm EX-10.1 24363
3 EX-31.1 tcon-ex31_1.htm EX-31.1 11276
4 EX-31.2 tcon-ex31_2.htm EX-31.2 10841
5 EX-32.1 tcon-ex32_1.htm EX-32.1 7331
6 EX-32.2 tcon-ex32_2.htm EX-32.2 7048
  Complete submission text file 0000950170-24-059752.txt   4669624

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcon-20240331.xsd EX-101.SCH 816739
43 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20240331_htm.xml XML 610017
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 24945485
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)